Evogene EVGN 深 滬
等待開盤 08-21 09:30:00 美东时间
0.5605
-0.040
-6.72%
華盛通- 最 高0.60
- 今 開0.60
- 成交量 22.83万股
- 最 低 0.5492
- 昨 收 0.6009
- 總市值 885.67万
- 52周最高 1.50
- 市盈率 靜 --
- 換手率 1.45%
- 52周最低 0.37
- 委 比 -33.33%
- 總股本 1580.14万
- 歷史最高 203.90
- 量 比 0.80
- 振 幅 8.45%
- 歷史最低 0.37
- 每 手 1
- 風險率 0.27%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Evogene Q2 EPS $(0.63) Misses $(0.27) Estimate, Sales $347.000K Beat $325.000K Estimate
Evogene (NASDAQ:EVGN) reported quarterly losses of $(0.63) per share which missed the analyst consensus estimate of $(0.27) by 133.33 percent. This is a 26 percent decrease over losses of $(0.50) per share from the same period last year. The company reported quarterly sales of $347.000 thousand whic...
08-18 19:04
Evogene Q2 2026 Earnings Preview
Evogene (EVGN) is scheduled to announce Q2 earnings results on Tuesday, August 18th, before market open. The consensus EPS Estimate is -$0.27 (+68.2% Y/Y) and the consensus Revenue Estimate is $0.33M ...
08-18 01:46
Freightos names Yaron Eldad as CFO
Freightos (CRGO) appointed Yaron Eldad as CFO, effective September 1, 2026. He will report to CEO Pablo Pinillos. Eldad brings more than 25 years of CFO and senior financial leadership experience acro...
08-17 18:56
Evogene Expands ATM Offering as Shareholder Activism Escalates
Evogene ( ($EVGN) ) has provided an announcement. Evogene Ltd. has increased th...
07-18 08:29
AgPlenus推出新型AI模型预测抗真菌活性
AgPlenus公司宣布推出其抗真菌效力预测模型（APP），这是一款机器学习模型，可直接从小分子的化学结构预测其抗真菌效力，扩展了Evogene旗下Che...
07-15 22:16
Evogene's AgPlenus Subsidiary Introduces Antifungal Potency Predictor
AgPlenus Ltd., a company developing novel, sustainable crop protection products and a subsidiary of Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN), today announced the launch of its Antifungal Potency Predictor (APP). This new machine learning model predicts the antifungal potency of small molecules direct...
07-15 19:33
Evogene Sets Up $2.9 Million At-the-Market Share Offering With A.G.P.
Evogene ( ($EVGN) ) has shared an announcement. On June 11, 2026, Evogene Ltd. ...
06-12 04:28
Full Transcript: Evogene Q1 2026 Earnings Call
Evogene (NASDAQ:EVGN) reported first-quarter financial results on Wednesday. The transcript from the company's first-quarter earnings call has been provided below. This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit https://www.benzinga.com/ap...
06-11 18:51
Evogene Reports Early Results for Cancer Therapy Study, Experimental Treatment Meets Safety Goal in First Human Trial
Evogene Ltd. ("Evogene") (NASDAQ:EVGN) (TASE: EVGN), a pioneering computational chemistry company specializing in generative design of small molecules for the pharmaceutical and agricultural industries, today announced
06-02 19:06
Evogene Files Secondary Offering Of 2,446,707 Shares By Selling Shareholder
- SEC filing
05-20 20:53
